Moderna MRNA, -4.36% CEO Stéphane Bancel has left no doubt whether he’s taking a glass half-full or half-empty approach to the emergence of the new omicron coronavirus variant. He told the Financial Times there’s no world where current vaccines are as effective as they have been against the delta variant. And he suggested the drop-off could be significant.